Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study.
Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Abdel Fattah M, Haquin J, Macgowan A, Grier S, Gibbs J, Chazan B, Yanovskay A, Ben Ami R, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Mauer S, Rodriguez-Bano J, Morales I, Oliver A, Ruiz De Gopegui E, Cano A, Machuca I, Gozalo-Marguello M, Martinez Martinez L, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstein Y, Leibovici L, Yahav D. Babich T, et al. Among authors: grier s. Clin Infect Dis. 2020 May 23;70(11):2270-2280. doi: 10.1093/cid/ciz668. Clin Infect Dis. 2020. PMID: 31323088
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study.
Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, MacGowan A, Grier S, Chazan B, Yanovskay A, Ami RB, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Maurer S, Rodriguez-Bano J, Morales I, Oliver A, de Gopegui ER, Cano A, Machuca I, Gozalo-Marguello M, Martinez-Martinez L, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstein Y, Leibovici L, Yahav D. Babich T, et al. Among authors: grier s. Int J Antimicrob Agents. 2020 Feb;55(2):105847. doi: 10.1016/j.ijantimicag.2019.11.004. Epub 2019 Nov 23. Int J Antimicrob Agents. 2020. PMID: 31770625
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study.
Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Abdel Fattah M, Haquin J, MacGowan A, Grier S, Gibbs J, Chazan B, Yanovskay A, Ami RB, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Mauer S, Rodriguez-Bano J, Morales I, Oliver A, Ruiz de Gopegui E, Cano A, Machuca I, Gozalo-Marguello M, Martinez LM, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstein Y, Leibovici L, Yahav D. Babich T, et al. Among authors: grier s. J Antimicrob Chemother. 2021 Jul 15;76(8):2172-2181. doi: 10.1093/jac/dkab134. J Antimicrob Chemother. 2021. PMID: 33993273
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study.
Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, Macgowan A, Grier S, Chazan B, Yanovskay A, Ami RB, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Mauer S, Rodríguez-Baño J, de Cueto M, Oliver A, de Gopegui ER, Cano A, Machuca I, Gozalo-Marguello M, Martinez-Martinez L, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstein Y, Leibovici L, Yahav D. Babich T, et al. Among authors: grier s. Infect Dis Ther. 2022 Aug;11(4):1505-1519. doi: 10.1007/s40121-022-00657-1. Epub 2022 May 25. Infect Dis Ther. 2022. PMID: 35612693 Free PMC article.
Risk Factors for Treatment Failure and Mortality Among Hospitalized Patients With Complicated Urinary Tract Infection: A Multicenter Retrospective Cohort Study (RESCUING Study Group).
Eliakim-Raz N, Babitch T, Shaw E, Addy I, Wiegand I, Vank C, Torre-Vallejo L, Joan-Miquel V, Steve M, Grier S, Stoddart M, Nienke C, Leo VDH, Vuong C, MacGowan A, Carratalà J, Leibovici L, Pujol M; RESCUING Study Group. Eliakim-Raz N, et al. Among authors: grier s. Clin Infect Dis. 2019 Jan 1;68(1):29-36. doi: 10.1093/cid/ciy418. Clin Infect Dis. 2019. PMID: 29788118
Risk factors for enterococcal urinary tract infections: a multinational, retrospective cohort study.
Turjeman A, Babich T, Pujol M, Carratalà J, Shaw E, Gomila-Grange A, Vuong C, Addy I, Wiegand I, Grier S, MacGowan A, Vank C, Cuperus N, van den Heuvel L, Leibovici L, Eliakim-Raz N; COMBACTE MAGNET WP5 RESCUING Study Group and Study Sites. Turjeman A, et al. Among authors: grier s. Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):2005-2010. doi: 10.1007/s10096-021-04207-4. Epub 2021 Mar 2. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33651207
Retrospective observational study to assess the clinical management and outcomes of hospitalised patients with complicated urinary tract infection in countries with high prevalence of multidrug resistant Gram-negative bacteria (RESCUING).
Shaw E, Addy I, Stoddart M, Vank C, Grier S, Wiegand I, Leibovici L, Eliakim-Raz N, Vallejo-Torres L, Morris S, MacGowan A, Carratalà J, Pujol M; COMBACTE-MAGNET Consortium. Shaw E, et al. Among authors: grier s. BMJ Open. 2016 Jul 29;6(7):e011500. doi: 10.1136/bmjopen-2016-011500. BMJ Open. 2016. PMID: 27473949 Free PMC article.
Patient and public involvement in infection clinical research.
Grier S, Gibson A, Micciche A, Berry E, MacGowan A. Grier S, et al. Clin Microbiol Infect. 2018 Nov;24(11):1121-1122. doi: 10.1016/j.cmi.2018.06.005. Epub 2018 Jun 12. Clin Microbiol Infect. 2018. PMID: 29906590 Free article. No abstract available.
Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study.
Vallejo-Torres L, Pujol M, Shaw E, Wiegand I, Vigo JM, Stoddart M, Grier S, Gibbs J, Vank C, Cuperus N, van den Heuvel L, Eliakim-Raz N, Carratala J, Vuong C, MacGowan A, Babich T, Leibovici L, Addy I, Morris S; RESCUING Study Group and Study Sites. Vallejo-Torres L, et al. Among authors: grier s. BMJ Open. 2018 Apr 12;8(4):e020251. doi: 10.1136/bmjopen-2017-020251. BMJ Open. 2018. PMID: 29654026 Free PMC article.
Risk factors for hospital readmission following complicated urinary tract infection.
Babich T, Eliakim-Raz N, Turjeman A, Pujol M, Carratalà J, Shaw E, Gomila Grange A, Vuong C, Addy I, Wiegand I, Grier S, MacGowan A, Vank C, van den Heuvel L, Leibovici L. Babich T, et al. Among authors: grier s. Sci Rep. 2021 Mar 25;11(1):6926. doi: 10.1038/s41598-021-86246-7. Sci Rep. 2021. PMID: 33767321 Free PMC article.
64 results